HBM Partners
↗Zug, Switzerland
HBM Partners is a leading Swiss-based healthcare investment firm managing approximately $2.1 billion in assets. Founded in 2001, the firm focuses on venture, growth, and buy-out financing for private companies, as well as strategic investments in public healthcare entities across Europe, North America, India, and China.
The firm serves as the investment advisor to HBM Healthcare Investments AG (SIX: HBMN), a publicly traded investment vehicle. HBM Partners is known for its deep scientific expertise, with a team largely comprised of PhDs and MDs who actively support portfolio companies through all stages of development, from discovery through commercialization and eventual exit via M&A or IPO.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$100M-$500M (Investment Income)
Founded:2001
Ownership:public
Status:operating
FUNDING
Stage:Not applicable (Investment Firm)
Investors:Institutional and private investors
STOCK
Exchange:SIX Swiss Exchange
Ticker:HBMN
Market Cap:~$1.7B CHF
PIPELINE
Stage:Commercial
Lead Drug Stage:Multiple FDA-approved products in portfolio
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy, RNA, Medtech Devices
Active Trials:150
Trial Phases:Phase 1: 40 | Phase 2: 60 | Phase 3: 30 | Phase 4: 20
FDA Approvals:50
EMA Approvals:40
CORPORATE STRUCTURE
Subsidiaries:HBM Healthcare Investments (Cayman) Ltd., HBM Private Equity India Ltd.
Key Partnerships:Sanofi (Collaboration with portfolio company Dren Bio), Roche (M&A deal for portfolio company 89Bio), Genmab (Acquisition of portfolio company Merus)
COMPETITION
Position:Leader
Competitors:BB Biotech, OrbiMed, Forbion, Sofinnova Partners, LSP (Life Sciences Partners)
LEADERSHIP
Key Executives:
Dr. Andreas Wicki - CEO
Erwin Troxler - CFO
Dr. Matthias Fehr - Head Private Equity
Scientific Founders:Henri Bernard Meier
Board Members:Hans Peter Hasler (Chairman), Dr. Rudolf Lanz, Dr. Stella X. Xu
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HBM Partners. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.